Want to join the conversation?
Christopher Schott of JPMorgan asks about why the Rx business is not seeing more margin erosion given the competitive dynamics and pricing. $PRGO CEO John Hendrickson said there have been pricing pressures, but looking at the whole basket of mix within the Rx business, it's still a profitable mix. And the acquisition has contributed to the margin.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.